Jin He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jin He has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- George I. Mias
Department of Biochemistry and Molecular Biology, Michigan State University
7 shared publications Mohammad B. Aljazi
Department of Biochemistry and Molecular Biology, College of Natural Science, Michigan State University, East Lansing, MI, United States
7 shared publicationsYan Wu
Department of Biochemistry & Molecular Biology, College of Nature Sciences, Michigan State University, East Lansing, MI 48824
7 shared publicationsYuen Gao
Department of Biochemistry and Molecular Biology, College of Natural Science, Michigan State University, East Lansing, MI, United States
7 shared publications- Yuen Gao
Department of Radiology, Michigan State University
6 shared publications Natalia Duque-Wilckens
Department of Physiology, College of Natural Science, Michigan State University, East Lansing, MI, USA
4 shared publications
Latest Publications
- Open Access
Integrated RNA sequencing reanalysis reveals reproducible matrix-immune signatures in idiopathic pulmonary fibrosis
In idiopathic pulmonary fibrosis (IPF), the lung is remodeled through coordinated epithelial, stromal, and immune-associated programs, but individual transcriptomic cohorts are often too small to separate shared disease signals from demographic and study-level variation. To increase statistical power while preserving study-aware interpretation, we integrated raw bulk lung RNA sequencing (RNA-seq) data from five well-annotated studies and analyzed 223 samples in a common framework that modeled sex, age, library layout and repeated sampling. IPF showed a broad and reproducible expression shift, with 2,443 genes meeting the differential-expression threshold of false discovery rate (FDR) < 0.05 and absolute log 2 fold change at least 1. The dominant program combined extracellular matrix remodeling, stromal and epithelial activation, complement and B-cell-related pathways, cilium-associated processes, and relative depletion of oxidative phosphorylation and proteasome pathways. Sex-stratified analyses recovered a shared fibrotic core with smaller sex-skewed components, whereas age-related disease effects were weaker and centered on immune activation. A leave-one-study-out elastic-net analysis using fixed disease-gene panels classified IPF across held-out studies, supporting cross-study portability of the core signature. This integrated reanalysis strengthens evidence for a stable matrix-immune IPF program and reinforces the view that core disease-associated transcriptional programs are reproducible across heterogeneous cohorts.
Open AccessIntegrated RNA sequencing reanalysis reveals reproducible matrix-immune signatures in idiopathic pulmonary fibrosis
In idiopathic pulmonary fibrosis (IPF), the lung is remodeled through coordinated epithelial, stromal, and immune-associated programs, but individual transcriptomic cohorts are often too small to separate shared disease signals from demographic and study-level variation. To increase statistical power while preserving study-aware interpretation, we integrated raw bulk lung RNA sequencing (RNA-seq) data from five well-annotated studies and analyzed 223 samples in a common framework that modeled sex, age, library layout and repeated sampling. IPF showed a broad and reproducible expression shift, with 2,443 genes meeting the differential-expression threshold of false discovery rate (FDR) < 0.05 and absolute log 2 fold change at least 1. The dominant program combined extracellular matrix remodeling, stromal and epithelial activation, complement and B-cell-related pathways, cilium-associated processes, and relative depletion of oxidative phosphorylation and proteasome pathways. Sex-stratified analyses recovered a shared fibrotic core with smaller sex-skewed components, whereas age-related disease effects were weaker and centered on immune activation. A leave-one-study-out elastic-net analysis using fixed disease-gene panels classified IPF across held-out studies, supporting cross-study portability of the core signature. This integrated reanalysis strengthens evidence for a stable matrix-immune IPF program and reinforces the view that core disease-associated transcriptional programs are reproducible across heterogeneous cohorts.
- Open Access
- 19 May 2026
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 20, 1832157
Histone demethylase KDM6B promotes postnatal oligodendrocyte maturation and cortical myelination
Introduction: Postnatal cortical myelination requires epigenetic activation of oligodendrocyte gene programs, but the role of histone demethylases in vivo remains unclear. Methods: We conditionally deleted Kdm6b in Emx1 + dorsal telencephalic progenitors and analyzed oligodendrocyte lineage progression, performed lineage-specific RNA-seq, assessed H3K27me3 occupancy by chromatin immunoprecipitation, and tested functional rescue via Sox10 induction. Results: Kdm6b deletion delayed cortical myelination and impaired oligodendrocyte maturation without affecting precursor density. Pre-myelinating and mature oligodendrocyte markers were reduced. RNA-seq revealed early suppression of Sox10 , followed by downregulation of myelin genes. Consistently, H3K27me3 enrichment increased at Sox10 regulatory regions. Sox10 induction partially rescued myelination deficits. Discussion: These findings define a KDM6B→ SOX10 axis that promotes oligodendrocyte maturation and cortical myelination by restricting repressive H3K27me3, providing mechanistic insight into epigenetic control of myelination with relevance to KDM6B-associated neurodevelopmental disorders.
- 19 May 2026
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 20, 1832157
Open AccessHistone demethylase KDM6B promotes postnatal oligodendrocyte maturation and cortical myelination
Introduction: Postnatal cortical myelination requires epigenetic activation of oligodendrocyte gene programs, but the role of histone demethylases in vivo remains unclear. Methods: We conditionally deleted Kdm6b in Emx1 + dorsal telencephalic progenitors and analyzed oligodendrocyte lineage progression, performed lineage-specific RNA-seq, assessed H3K27me3 occupancy by chromatin immunoprecipitation, and tested functional rescue via Sox10 induction. Results: Kdm6b deletion delayed cortical myelination and impaired oligodendrocyte maturation without affecting precursor density. Pre-myelinating and mature oligodendrocyte markers were reduced. RNA-seq revealed early suppression of Sox10 , followed by downregulation of myelin genes. Consistently, H3K27me3 enrichment increased at Sox10 regulatory regions. Sox10 induction partially rescued myelination deficits. Discussion: These findings define a KDM6B→ SOX10 axis that promotes oligodendrocyte maturation and cortical myelination by restricting repressive H3K27me3, providing mechanistic insight into epigenetic control of myelination with relevance to KDM6B-associated neurodevelopmental disorders.
- Open Access
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eadv1236
Transcriptional regulation of ventral hippocampus-nucleus accumbens circuit excitability drives cocaine seeking
Ventral hippocampus (vHPC) CA1 pyramidal neurons send glutamatergic projections to nucleus accumbens (NAc), and this vHPC-NAc circuit mediates cocaine seeking and reward, but it is unclear whether vHPC-NAc neuron properties are modulated by cocaine exposure to drive subsequent behavior. The immediate early gene transcription factor FosB/ΔFosB is induced throughout the brain by cocaine and is critical for cocaine seeking, but its function in vHPC-NAc neurons is not understood. We now show that circuit-specific knockout of FosB/ΔFosB in vHPC-NAc neurons impaired cocaine reward expression and forced abstinence–induced seeking. We also found that vHPC-NAc excitability was decreased by experimenter-administered repeated cocaine and cocaine self-administration, and this cocaine-induced excitability decrease was mediated by ΔFosB expression. To uncover the mechanism of this change in circuit function, we used circuit-specific translating ribosome affinity purification to assess cocaine-induced, FosB/ΔFosB-dependent changes in gene expression in vHPC-NAc. We found that cocaine causes a FosB/ΔFosB-dependent increase in the expression of calreticulin, an endoplasmic reticulum–resident calcium-buffering protein. Calreticulin expression mediated vHPC-NAc excitability and was necessary for cocaine reward. These findings uncover a noncanonical mechanism by which cocaine increases calreticulin in vHPC leading to decreased vHPC-NAc excitability and drives cocaine seeking and reward.
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eadv1236
Open AccessTranscriptional regulation of ventral hippocampus-nucleus accumbens circuit excitability drives cocaine seeking
Ventral hippocampus (vHPC) CA1 pyramidal neurons send glutamatergic projections to nucleus accumbens (NAc), and this vHPC-NAc circuit mediates cocaine seeking and reward, but it is unclear whether vHPC-NAc neuron properties are modulated by cocaine exposure to drive subsequent behavior. The immediate early gene transcription factor FosB/ΔFosB is induced throughout the brain by cocaine and is critical for cocaine seeking, but its function in vHPC-NAc neurons is not understood. We now show that circuit-specific knockout of FosB/ΔFosB in vHPC-NAc neurons impaired cocaine reward expression and forced abstinence–induced seeking. We also found that vHPC-NAc excitability was decreased by experimenter-administered repeated cocaine and cocaine self-administration, and this cocaine-induced excitability decrease was mediated by ΔFosB expression. To uncover the mechanism of this change in circuit function, we used circuit-specific translating ribosome affinity purification to assess cocaine-induced, FosB/ΔFosB-dependent changes in gene expression in vHPC-NAc. We found that cocaine causes a FosB/ΔFosB-dependent increase in the expression of calreticulin, an endoplasmic reticulum–resident calcium-buffering protein. Calreticulin expression mediated vHPC-NAc excitability and was necessary for cocaine reward. These findings uncover a noncanonical mechanism by which cocaine increases calreticulin in vHPC leading to decreased vHPC-NAc excitability and drives cocaine seeking and reward.
- Open Access
Histone Demethylase KDM6B Promotes Postnatal Oligodendrocyte Development and Cortical Myelination
Myelination in the postnatal cortex requires epigenetic programs that activate oligodendrocyte gene networks. Here we show that the histone H3K27me3 demethylase KDM6B promotes this process in vivo. Conditional Kdm6b deletion (Kdm6b-cKO) in Emx1⁺ dorsal telencephalic progenitors caused delayed cortical myelination. Lineage-specific RNA-seq revealed that the oligodendrocyte master regulator Sox10 was significantly reduced, as well as myelination effectors, indicating impaired oligodendrocyte maturation. Chromatin immunoprecipitation assays of the same lineage showed increased H3K27me3 at promoter-proximal regions of Sox10, consistent with loss of KDM6B-mediated de-repression. Temporally controlled Sox10 induction partially rescued myelination in Kdm6b-cKO mice. These findings define a KDM6B→SOX10 axis that licenses oligodendrocyte development and cortical myelination by removing repressive H3K27me3 and sustaining active chromatin, with implications for KDM6B-related neurodevelopmental disorders.
Open AccessHistone Demethylase KDM6B Promotes Postnatal Oligodendrocyte Development and Cortical Myelination
Myelination in the postnatal cortex requires epigenetic programs that activate oligodendrocyte gene networks. Here we show that the histone H3K27me3 demethylase KDM6B promotes this process in vivo. Conditional Kdm6b deletion (Kdm6b-cKO) in Emx1⁺ dorsal telencephalic progenitors caused delayed cortical myelination. Lineage-specific RNA-seq revealed that the oligodendrocyte master regulator Sox10 was significantly reduced, as well as myelination effectors, indicating impaired oligodendrocyte maturation. Chromatin immunoprecipitation assays of the same lineage showed increased H3K27me3 at promoter-proximal regions of Sox10, consistent with loss of KDM6B-mediated de-repression. Temporally controlled Sox10 induction partially rescued myelination in Kdm6b-cKO mice. These findings define a KDM6B→SOX10 axis that licenses oligodendrocyte development and cortical myelination by removing repressive H3K27me3 and sustaining active chromatin, with implications for KDM6B-related neurodevelopmental disorders.
- 8 November 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 52 (1) , 39-50
KDM2A and KDM2B protect a subset of CpG islands from DNA methylation
- 8 November 2024
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 52 (1) , 39-50
KDM2A and KDM2B protect a subset of CpG islands from DNA methylation
- Open Access
SMYD5 is a regulator of the mild hypothermia response
Organisms have homeostatic mechanisms to respond to cold to ensure survival including the activation of the neuroprotective mild hypothermia response (MHR) in mammals at 32°C. We show activation of the MHR by one FDA-approved medication, Entacapone, a proof-of-principle that the MHR can be medically manipulated. Utilizing a forward CRISPR-Cas9 mutagenesis screen, we identify the histone lysine methyltransferase SMYD5 as an epigenetic gatekeeper of the MHR. SMYD5 represses the key MHR gene SP1 at euthermia but not at 32°C. This repression is mirrored by temperature-dependent levels of H3K36me3 at the SP1-locus and globally indicating the mammalian MHR is regulated at the level of histone modifications. We identified 45 additional SMYD5-temperature dependent genes suggesting a broader MHR-related role for SMYD5. Our study provides an example of how the epigenetic machinery integrates environmental cues into the genetic circuitry of mammalian cells and suggests novel therapeutic avenues for neuroprotection after catastrophic events.
Open AccessSMYD5 is a regulator of the mild hypothermia response
Organisms have homeostatic mechanisms to respond to cold to ensure survival including the activation of the neuroprotective mild hypothermia response (MHR) in mammals at 32°C. We show activation of the MHR by one FDA-approved medication, Entacapone, a proof-of-principle that the MHR can be medically manipulated. Utilizing a forward CRISPR-Cas9 mutagenesis screen, we identify the histone lysine methyltransferase SMYD5 as an epigenetic gatekeeper of the MHR. SMYD5 represses the key MHR gene SP1 at euthermia but not at 32°C. This repression is mirrored by temperature-dependent levels of H3K36me3 at the SP1-locus and globally indicating the mammalian MHR is regulated at the level of histone modifications. We identified 45 additional SMYD5-temperature dependent genes suggesting a broader MHR-related role for SMYD5. Our study provides an example of how the epigenetic machinery integrates environmental cues into the genetic circuitry of mammalian cells and suggests novel therapeutic avenues for neuroprotection after catastrophic events.
- Open Access
- 31 May 2022
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 16, 905783
Kdm6b Haploinsufficiency Causes ASD/ADHD-Like Behavioral Deficits in Mice
Autism spectrum disorder (ASD) is a neurodevelopmental disease that has intellectual disability (ID) and attention-deficit/hyperactivity disorder (ADHD) as its common comorbidities. Recent genetic and clinical studies report that KDM6B, a gene encoding a histone H3 lysine 27-specific demethylase, is one of the highest ASD risk genes. However, the relationship between KDM6B mutations and neurodevelopmental diseases remains unclear. Here we use an animal model to show that genetic deletion of one Kdm6b allele in mice leads to autistic-like impaired sociability and object recognition memory. In addition, the mutant mice display markedly increased locomotor activity and impulsivity, two ADHD-like behavioral traits that are ameliorated by methylphenidate treatment. Thus, our study not only uncovers a potential causal link between disruptive KDM6B mutations and ASD/ADHD-like behavioral deficits but also provides a new mouse model for studying the cellular and molecular mechanisms underlying the Kdm6b-mutation-related neurodevelopmental diseases.
- 31 May 2022
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 16, 905783
Open AccessKdm6b Haploinsufficiency Causes ASD/ADHD-Like Behavioral Deficits in Mice
Autism spectrum disorder (ASD) is a neurodevelopmental disease that has intellectual disability (ID) and attention-deficit/hyperactivity disorder (ADHD) as its common comorbidities. Recent genetic and clinical studies report that KDM6B, a gene encoding a histone H3 lysine 27-specific demethylase, is one of the highest ASD risk genes. However, the relationship between KDM6B mutations and neurodevelopmental diseases remains unclear. Here we use an animal model to show that genetic deletion of one Kdm6b allele in mice leads to autistic-like impaired sociability and object recognition memory. In addition, the mutant mice display markedly increased locomotor activity and impulsivity, two ADHD-like behavioral traits that are ameliorated by methylphenidate treatment. Thus, our study not only uncovers a potential causal link between disruptive KDM6B mutations and ASD/ADHD-like behavioral deficits but also provides a new mouse model for studying the cellular and molecular mechanisms underlying the Kdm6b-mutation-related neurodevelopmental diseases.
- Open Access
- 5 April 2022
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 16, 873466
Neural Hyperactivity Is a Core Pathophysiological Change Induced by Deletion of a High Autism Risk Gene Ash1L in the Mouse Brain
ASH1L is one of the highest risk genes associated with autism spectrum disorder (ASD) and intellectual disability (ID). Our recent studies demonstrate that loss of Ash1l in the mouse brain is sufficient to induce ASD/ID-like behavioral and cognitive deficits, suggesting that disruptive ASH1L mutations are likely to have a positive correlation with ASD/ID genesis. However, the core pathophysiological changes in the Ash1l-deficient brain remain largely unknown. Here we show that loss of Ash1l in the mouse brain causes locomotor hyperactivity, high metabolic activity, and hyperactivity-related disturbed sleep and lipid metabolic changes. In addition, the mutant mice display lower thresholds for the convulsant reagent-induced epilepsy and increased neuronal activities in multiple brain regions. Thus, our current study reveals that neural hyperactivity is a core pathophysiological change in the Ash1l-deficient mouse brain, which may function as a brain-level mechanism leading to the Ash1l-deletion-induced brain functional abnormalities and autistic-like behavioral deficits.
- 5 April 2022
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 16, 873466
Open AccessNeural Hyperactivity Is a Core Pathophysiological Change Induced by Deletion of a High Autism Risk Gene Ash1L in the Mouse Brain
ASH1L is one of the highest risk genes associated with autism spectrum disorder (ASD) and intellectual disability (ID). Our recent studies demonstrate that loss of Ash1l in the mouse brain is sufficient to induce ASD/ID-like behavioral and cognitive deficits, suggesting that disruptive ASH1L mutations are likely to have a positive correlation with ASD/ID genesis. However, the core pathophysiological changes in the Ash1l-deficient brain remain largely unknown. Here we show that loss of Ash1l in the mouse brain causes locomotor hyperactivity, high metabolic activity, and hyperactivity-related disturbed sleep and lipid metabolic changes. In addition, the mutant mice display lower thresholds for the convulsant reagent-induced epilepsy and increased neuronal activities in multiple brain regions. Thus, our current study reveals that neural hyperactivity is a core pathophysiological change in the Ash1l-deficient mouse brain, which may function as a brain-level mechanism leading to the Ash1l-deletion-induced brain functional abnormalities and autistic-like behavioral deficits.
- Open Access
- 12 February 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 599, 142-147
SMYD5 is a histone H3-specific methyltransferase mediating mono-methylation of histone H3 lysine 36 and 37
- 12 February 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 599, 142-147
Open AccessSMYD5 is a histone H3-specific methyltransferase mediating mono-methylation of histone H3 lysine 36 and 37
- Open Access
Neural hyperactivity is a core pathophysiological change induced by deletion of an autism risk gene Ash1l in the mouse brain
Autism spectrum disorder (ASD) is a neurodevelopmental disease associated with various gene mutations. Previous genetic and clinical studies report that mutations of the epigenetic gene ASH1L are highly associated with human ASD and intellectual disability (ID). Recent studies demonstrate that loss of Ash1l in the mouse brain is sufficient to induce ASD/ID-like behavioral and cognitive memory deficits, suggesting that disruptive ASH1L mutations are likely to be the causative driver leading to the ASD/ID pathogenesis in human patients. However, the brain pathophysiological changes underlying the Ash1l -deletion-induced ASD/ID-like behavioral and memory deficits remain unknown. Here we show loss of Ash1l in the mouse brain causes locomotor hyperactivity and higher metabolic rates . In addition, the mutant mice display lower thresholds for the convulsant reagent-induced epilepsy and increased neuronal activities in broad brain areas. Thus, our current study reveals that neural hyperactivity is a core pathophysiological change in the Ash1l -deficient mouse brain, which provides a brain-level basis for further studying the cellular and molecular mechanisms underlying the Ash1l -deletion-induced ASD/ID pathogenesis.
Open AccessNeural hyperactivity is a core pathophysiological change induced by deletion of an autism risk gene Ash1l in the mouse brain
Autism spectrum disorder (ASD) is a neurodevelopmental disease associated with various gene mutations. Previous genetic and clinical studies report that mutations of the epigenetic gene ASH1L are highly associated with human ASD and intellectual disability (ID). Recent studies demonstrate that loss of Ash1l in the mouse brain is sufficient to induce ASD/ID-like behavioral and cognitive memory deficits, suggesting that disruptive ASH1L mutations are likely to be the causative driver leading to the ASD/ID pathogenesis in human patients. However, the brain pathophysiological changes underlying the Ash1l -deletion-induced ASD/ID-like behavioral and memory deficits remain unknown. Here we show loss of Ash1l in the mouse brain causes locomotor hyperactivity and higher metabolic rates . In addition, the mutant mice display lower thresholds for the convulsant reagent-induced epilepsy and increased neuronal activities in broad brain areas. Thus, our current study reveals that neural hyperactivity is a core pathophysiological change in the Ash1l -deficient mouse brain, which provides a brain-level basis for further studying the cellular and molecular mechanisms underlying the Ash1l -deletion-induced ASD/ID pathogenesis.